Actos Manufacturer Faces Additional Lawsuits
The pharmaceutical manufacturer, Takeda, who markets the drugs Actos, Prevacid, Uloric, and others is now facing additional lawsuits from patients alleging injuries. The U.S. Food and Drug Administration (FDA) issued a safety announcement in September 2010 that indicated an increased risk for bladder cancer in patients taking Actos (pioglitazone) for the treatment of their Type II diabetes mellitus. While the FDA has not fully concluded its study of the drug, it has stated that patients should be aware of the increased risk for developing bladder cancer as a result of taking this drug.
Patients taking the drug Uloric, also manufactured and marketed by Takeda, for the treatment of gout have filed complaints alleging that Takeda failed to warn patients about dangerous side effects when using Uloric in combination with other drugs [the filing document is no longer available from the source]. Drug combination side effects can include: severe bleeding & kidney failure, bone marrow failure, and death.
Our product liability/personal injury experts can discuss your legal options with you if you or a loved one is experiencing any side effects after using Actos or other drugs to treat Type II diabetes, please contact CohenMalad, LLP to seek the compensation you deserve.
